Prenatal Detection of Congenital Heart Disease: Identification of High Risk Groups and Normal Sonographic Appearances

Ferencz C Rubin JD McCarter RJ Brenner JI Neill C Perry LW Hepner SI Downing JW . Congenital heart disease: Prevalence at livebirth. The Baltimore-Washington infant study. Am J Epidem 1985; 121: 31–36.

Routine ultrasound screening in pregnancy: Protocol, standards and training. Royal College of Obstetricians and Gynaecologists—report of the RCOG working party July 2000.

Bull C (for the British Paediatric Cardiac Association).Current and potential impact of fetal diagnosis on prevalence and spectrum of serious congenital heart disease at term in the UK. Lancet 1999; 354: 1242–1247.

Burn J Brennan P Little J Holloway S Coffey R Somerville J Dennis NR Allan L Arnold R Deanfield JE Godman M Houston A Keeton B Oakley C Scott O Silove E Wilkinson J Pembrey M Hunter AS . Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study. Lancet 1998; 351: 311–316.

Allan LD Crawford DC Chita SK Anderson RH Tynan MJ Familial recurrence of congenital heart disease in a prospective series of mothers referred for fetal echocardiography. Am J Cardiol 1986; 58: 334–7.

Pandya PP Snijders RJM Johnson SP De Lourdes Brizot M Nicolaides KH . Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation. Br J Obstet Gynaecol 1995; 102: 957–962.

Hyett J Perdu M Sharland G Snijders R Nicolaides K . Using fetal nuchal translucency to screen for major congenital cardiac defects at 10–14 weeks of gestation: population based cohort study. Brit Med J 1999; 318: 81–85.

Ghi T Huggon IC Zosmer N Nicolaides KH . Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype. Ultrasound Obstet Gynecol 2001; 18: 610–614.

Simpson JM Sharland GK . Nuchal translucency and congenital heart defects: heart failure or not? Ultrasound Obstet Gynecol 2000; 16: 30–36.

Mavrides E Cobian-Sanchez F Tekay A Moscoso G Campbell S Thilaganathan B Carvalho JS . Limitations of using first-trimester nuchal translucency measurement in routine screening for major congenital heart defects Ultrasound Obstet Gynecol 2001; 17: 106–110.

Michailidis GD Economides DL . Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses. Ultrasound Obstet Gynecol 2001; 17: 102–105.

Meyer-Wittkopf M Simpson JM Sharland GK . Incidence of congenital heart defects in fetuses of diabetic mothers: a retrospective study of 326 cases. Ultrasound Obstet Gynecol 1996; 8: 8–10.

Simpson JM Jones A Callaghan N Sharland GK . Accuracy and limitations of transabdominal fetal echocardiography at 12–15 weeks gestation in a population at high risk for congenital heart disease. Br J Obstet Gynecol 2000; 107: 1492–1497.

Yagel S Cohen SM Achiron R . Examination of the fetal heart by five short-axis views: a proposed screening method for comprehensive cardiac evaluation. Ultrasound Obstet Gynecol 2001; 17: 367–9.

Stumpflen I Stumpflen A Wimmer M Bernaschek G . Effect of detailed fetal echocardiography as part of routine prenatal ultrasonographic screening on detection of congenital heart disease. Lancet 1996; 348: 854–7.

Achiron R Glaser J Gelernter I Hegesh J Yagel S . Extended fetal echocardiographic examination for detecting cardiac malformations in low risk pregnancies. Brit Med J 1992; 304: 671–674.